Document is current
Any future updates will be listed below
-
Authors
Meloni, Antonella
Pistoia, Laura
Positano, Vincenzo
De Luca, Antonio
Martini, Nicola
Spasiano, Anna
Fotzi, Ilaria
Bitti, Pier Paolo
Visceglie, Domenico
Alberini, Gianna
Sinagra, Gianfranco
Pepe, Alessia
Cademartiri, Filippo https://orcid.org/0000-0002-0579-3279
-
Funding
Funding for this research was provided by:
The E-MIOT project receives “no-profit support” from industrial sponsorships (Chiesi Farmaceutici S.p.A. and Bayer).
- License Information
-
More Information
Article History
Received: 1 June 2022
Revised: 27 July 2022
Accepted: 18 August 2022
First Online: 6 September 2022
Declarations
:
: The scientific guarantor of this publication is Filippo Cademartiri.
: The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
: One of the authors has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: Some study subjects or cohorts have been previously reported in: Meloni A, Martini N, Positano V, et al. Journal of Cardiovascular Magnetic Resonance; 2021;23(1):70.
: • prospective• cross sectional study/observational• performed at one institution
